Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003954 · ClinicalTrials.gov registry record · Phase 1
Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
A Phase 1 study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00003954 is a Phase 1 study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 40 participants.
The verdict
NCT00003954, a Phase 1 study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
In this study donor bone marrow transplantation is divided into a two step process to try to significantly reduce the side effects of the procedure yet still provide patients with multiple myeloma the benefits of this procedure
Interventions
- PROCEDURE autologous hematopoietic stem cell transplantation
- DRUG melphalan
- PROCEDURE peripheral blood stem cell transplantation
- RADIATION total-body irradiation
- PROCEDURE autologous bone marrow transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 1999-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003954
The ClinicalTrials.gov registry entry for NCT00003954 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which autologous hematopoietic stem cell transplantation is the first listed.
NCT00003954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003954 about?
NCT00003954 is a clinical study titled "Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma". In this study donor bone marrow transplantation is divided into a two step process to try to significantly reduce the side effects of the procedure yet still provide patients with multiple myeloma the benefits of this procedure
What is the current status of trial NCT00003954?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 1999-03.
What interventions are being tested in trial NCT00003954?
The interventions under investigation include: autologous hematopoietic stem cell transplantation (PROCEDURE), melphalan (DRUG), peripheral blood stem cell transplantation (PROCEDURE), total-body irradiation (RADIATION), autologous bone marrow transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT00003954?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.